Ya-Fang Chang

2.0k total citations
17 papers, 932 citations indexed

About

Ya-Fang Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ya-Fang Chang has authored 17 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Ya-Fang Chang's work include CAR-T cell therapy research (5 papers), Cancer Research and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Ya-Fang Chang is often cited by papers focused on CAR-T cell therapy research (5 papers), Cancer Research and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Ya-Fang Chang collaborates with scholars based in Taiwan, United States and United Kingdom. Ya-Fang Chang's co-authors include Jeng‐Jong Hwang, Hui-Yen Chuang, Huiping Liu, Jessica Bockhorn, Geoffrey L. Greene, Aleix Prat, Rachel Dalton, Simo Huang, Dezheng Huo and Ren-Shyan Liu and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Ya-Fang Chang

17 papers receiving 925 citations

Peers

Countries citing papers authored by Ya-Fang Chang

Since Specialization

Citations

This map shows the geographic impact of Ya-Fang Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Fang Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Fang Chang more than expected).

Fields of papers citing papers by Ya-Fang Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya-Fang Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Fang Chang. The network helps show where Ya-Fang Chang may publish in the future.

Co-authorship network of co-authors of Ya-Fang Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ya-Fang Chang. A scholar is included among the top collaborators of Ya-Fang Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-Fang Chang. Ya-Fang Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling 2021 ·Cancers ·Robert F. Gruener, Alexander Ling, Ya-Fang Chang, Gladys Morrison, Paul Geeleher, Geoffrey L. Greene, R. Stephanie Huang	10
2	EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer 2021 ·Theranostics ·Xia Liu, Valery Adorno-Cruz, Ya-Fang Chang, Yuzhi Jia, Madoka Kawaguchi, Nurmaa K. Dashzeveg, Rokana Taftaf, Erika K. Ramos, Emma J. Schuster, Lamiaa El-Shennawy, Dhwani Patel, Youbin Zhang, Massimo Cristofanilli, Huiping Liu	52
3	miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway 2016 ·Clinical Cancer Research ·Ravand Samaeekia, Valery Adorno-Cruz, Jessica Bockhorn, Ya-Fang Chang, Simo Huang, Aleix Prat, (unknown), Golam Kibria, Dezheng Huo, Hui Zheng, Rachel Dalton, (unknown), (unknown), Huiping Liu	106
4	Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer 2016 ·Science Advances ·Hari Singhal, Marianne E. Greene, Gerard A. Tarulli, (unknown), (unknown), Muriel Lainé, Ya-Fang Chang, Shihong Ma, (unknown), Ganesh V. Raj, Theresa E. Hickey, Wayne D. Tilley, Geoffrey L. Greene	105
5	Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice 2015 ·Oncotarget ·Fei‐Ting Hsu, Tzu‐Chun Chen, Hui-Yen Chuang, Ya-Fang Chang, Jeng‐Jong Hwang	25
6	Differentiation and Loss of Malignant Character of Spontaneous Pulmonary Metastases in Patient-Derived Breast Cancer Models 2014 ·Cancer Research ·Jessica Bockhorn, Aleix Prat, Ya-Fang Chang, Xia Liu, Simo Huang, Meng Shang, Chika Nwachukwu, (unknown), J. Chuck Harrell, Olufunmilayo I. Olopade, Charles M. Perou, Huiping Liu	33
7	T-Cell Autophagy Deficiency Increases Mortality and Suppresses Immune Responses after Sepsis 2014 ·PLoS ONE ·Chih‐Wen Lin, Steven Lo, Chin Hsu, Chi-Hsun Hsieh, Ya-Fang Chang, (unknown), Y. H. Kao, Chih-Che Lin, Ming‐Lung Yu, Shyng‐Shiou F. Yuan, Ya-Ching Hsieh	54
8	Serial Low Doses of Sorafenib Enhance Therapeutic Efficacy of Adoptive T Cell Therapy in a Murine Model by Improving Tumor Microenvironment 2014 ·PLoS ONE ·Hui-Yen Chuang, Ya-Fang Chang, Ren-Shyan Liu, Jeng‐Jong Hwang	32
9	Complete Activation of Autophagic Process Attenuates Liver Injury and Improves Survival in Septic Mice 2013 ·Shock ·Chih‐Wen Lin, Steven Lo, (unknown), (unknown), Po‐Huang Lee, Ya-Fang Chang, Po-Lin Kuo, Ming‐Lung Yu, Shyng‐Shiou F. Yuan, Ya-Ching Hsieh	69
10	MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 2013 ·Nature Communications ·Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, Simo Huang, Aleix Prat, (unknown), Ya-Fang Chang, Dezheng Huo, Yujia Wen, Kaitlin E. Swanson, (unknown), Jun Lü, Seo Young Park, M. Eileen Dolan, Charles M. Perou, Olufunmilayo I. Olopade, Michael F. Clarke, Geoffrey L. Greene, Huiping Liu	203
11	Immunomodulation of Curcumin on Adoptive Therapy with T Cell Functional Imaging in Mice 2011 ·Cancer Prevention Research ·Ya-Fang Chang, Hui-Yen Chuang, (unknown), Ren-Shyan Liu, Sanjiv S. Gambhir, Jeng‐Jong Hwang	51
12	Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal 2011 ·Biomedicine & Pharmacotherapy ·Hui-Yen Chuang, Ya-Fang Chang, Jeng‐Jong Hwang	70
13	Removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sorting 2011 ·Journal of Virological Methods ·Huiping Liu, Jessica Bockhorn, Rachel Dalton, Ya-Fang Chang, Dalong Qian, Lois A. Zitzow, Michael F. Clarke, Geoffrey L. Greene	21
14	Longitudinal, Noninvasive Imaging of T-Cell Effector Function and Proliferation in Living Subjects 2010 ·Cancer Research ·Manishkumar Patel, Ya-Fang Chang, Ian Y. Chen, Michael H. Bachmann, Xinrui Yan, Christopher H. Contag, Sanjiv S. Gambhir	45
15	Therapeutic Efficacy Evaluation of Curcumin on Human Oral Squamous Cell Carcinoma Xenograft Using Multimodalities of Molecular Imaging 2010 ·The American Journal of Chinese Medicine ·Yu-Chuan Lin, (unknown), Yu-Cheng Kuo, Ya-Fang Chang, Yi‐Jang Lee, Jeng‐Jong Hwang	30
16	Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts 2006 ·Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment ·(unknown), Jeng‐Jong Hwang, Yun-Long Tseng, Hsin-Ell Wang, Ya-Fang Chang, (unknown), Gann Ting, (unknown), Shyh-Jen Wang	15
17	Monitoring of tumor growth and metastasis potential in MDA-MB-435s/tk-luc human breast cancer xenografts 2006 ·Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment ·Ya-Fang Chang, (unknown), Hsin-Ell Wang, (unknown), Fei Pang, Jeng‐Jong Hwang	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact